'en:bencyclane'
(id=6732537 ; fe=en:bencyclane ; type=1 ; niveau=200 ;
luminosité=25 ;
somme entrante=2775 creation date=2017-06-21 touchdate=2025-07-30 12:42:45.000) ≈ 83 relations sortantes
- en:bencyclane --
r_associated #0: 43 / 1 ->
en:nisoldipine
n1=en:bencyclane | n2=en:nisoldipine | rel=r_associated | relid=0 | w=43
- en:bencyclane --
r_associated #0: 39 / 0.907 ->
en:felodipine
n1=en:bencyclane | n2=en:felodipine | rel=r_associated | relid=0 | w=39
- en:bencyclane --
r_associated #0: 39 / 0.907 ->
en:nexopamil
n1=en:bencyclane | n2=en:nexopamil | rel=r_associated | relid=0 | w=39
- en:bencyclane --
r_associated #0: 38 / 0.884 ->
en:carboxyamidotriazole
n1=en:bencyclane | n2=en:carboxyamidotriazole | rel=r_associated | relid=0 | w=38
- en:bencyclane --
r_associated #0: 35 / 0.814 ->
en:flordipine
n1=en:bencyclane | n2=en:flordipine | rel=r_associated | relid=0 | w=35
- en:bencyclane --
r_associated #0: 35 / 0.814 ->
en:perhexiline maleate
n1=en:bencyclane | n2=en:perhexiline maleate | rel=r_associated | relid=0 | w=35
- en:bencyclane --
r_associated #0: 35 / 0.814 ->
en:semotiadil
n1=en:bencyclane | n2=en:semotiadil | rel=r_associated | relid=0 | w=35
- en:bencyclane --
r_associated #0: 34 / 0.791 ->
en:diltiazem hydrochloride
n1=en:bencyclane | n2=en:diltiazem hydrochloride | rel=r_associated | relid=0 | w=34
- en:bencyclane --
r_associated #0: 34 / 0.791 ->
en:falipamil
n1=en:bencyclane | n2=en:falipamil | rel=r_associated | relid=0 | w=34
- en:bencyclane --
r_associated #0: 34 / 0.791 ->
en:gallopamil hydrochloride
n1=en:bencyclane | n2=en:gallopamil hydrochloride | rel=r_associated | relid=0 | w=34
- en:bencyclane --
r_associated #0: 34 / 0.791 ->
en:levemopamil
n1=en:bencyclane | n2=en:levemopamil | rel=r_associated | relid=0 | w=34
- en:bencyclane --
r_associated #0: 34 / 0.791 ->
en:nicardipine
n1=en:bencyclane | n2=en:nicardipine | rel=r_associated | relid=0 | w=34
- en:bencyclane --
r_associated #0: 32 / 0.744 ->
en:amlodipine besylate
n1=en:bencyclane | n2=en:amlodipine besylate | rel=r_associated | relid=0 | w=32
- en:bencyclane --
r_associated #0: 32 / 0.744 ->
en:belfosdil
n1=en:bencyclane | n2=en:belfosdil | rel=r_associated | relid=0 | w=32
- en:bencyclane --
r_associated #0: 32 / 0.744 ->
en:bencyclane fumarate
n1=en:bencyclane | n2=en:bencyclane fumarate | rel=r_associated | relid=0 | w=32
- en:bencyclane --
r_associated #0: 32 / 0.744 ->
en:elgodipine
n1=en:bencyclane | n2=en:elgodipine | rel=r_associated | relid=0 | w=32
- en:bencyclane --
r_associated #0: 32 / 0.744 ->
en:monatepil
n1=en:bencyclane | n2=en:monatepil | rel=r_associated | relid=0 | w=32
- en:bencyclane --
r_associated #0: 32 / 0.744 ->
en:olradipine
n1=en:bencyclane | n2=en:olradipine | rel=r_associated | relid=0 | w=32
- en:bencyclane --
r_associated #0: 31 / 0.721 ->
en:anipamil
n1=en:bencyclane | n2=en:anipamil | rel=r_associated | relid=0 | w=31
- en:bencyclane --
r_associated #0: 31 / 0.721 ->
en:caroverine hydrochloride
n1=en:bencyclane | n2=en:caroverine hydrochloride | rel=r_associated | relid=0 | w=31
- en:bencyclane --
r_associated #0: 31 / 0.721 ->
en:clevidipine
n1=en:bencyclane | n2=en:clevidipine | rel=r_associated | relid=0 | w=31
- en:bencyclane --
r_associated #0: 31 / 0.721 ->
en:dexniguldipine
n1=en:bencyclane | n2=en:dexniguldipine | rel=r_associated | relid=0 | w=31
- en:bencyclane --
r_associated #0: 31 / 0.721 ->
en:lifarizine
n1=en:bencyclane | n2=en:lifarizine | rel=r_associated | relid=0 | w=31
- en:bencyclane --
r_associated #0: 31 / 0.721 ->
en:manidipine
n1=en:bencyclane | n2=en:manidipine | rel=r_associated | relid=0 | w=31
- en:bencyclane --
r_associated #0: 31 / 0.721 ->
en:nilvadipine
n1=en:bencyclane | n2=en:nilvadipine | rel=r_associated | relid=0 | w=31
- en:bencyclane --
r_associated #0: 31 / 0.721 ->
en:nitrendipine
n1=en:bencyclane | n2=en:nitrendipine | rel=r_associated | relid=0 | w=31
- en:bencyclane --
r_associated #0: 30 / 0.698 ->
en:azulenes
n1=en:bencyclane | n2=en:azulenes | rel=r_associated | relid=0 | w=30
- en:bencyclane --
r_associated #0: 30 / 0.698 ->
en:bepridil
n1=en:bencyclane | n2=en:bepridil | rel=r_associated | relid=0 | w=30
- en:bencyclane --
r_associated #0: 30 / 0.698 ->
en:diltiazem
n1=en:bencyclane | n2=en:diltiazem | rel=r_associated | relid=0 | w=30
- en:bencyclane --
r_associated #0: 30 / 0.698 ->
en:diproteverine
n1=en:bencyclane | n2=en:diproteverine | rel=r_associated | relid=0 | w=30
- en:bencyclane --
r_associated #0: 30 / 0.698 ->
en:efonidipine
n1=en:bencyclane | n2=en:efonidipine | rel=r_associated | relid=0 | w=30
- en:bencyclane --
r_associated #0: 30 / 0.698 ->
en:halidor
n1=en:bencyclane | n2=en:halidor | rel=r_associated | relid=0 | w=30
- en:bencyclane --
r_associated #0: 30 / 0.698 ->
en:lacidipine
n1=en:bencyclane | n2=en:lacidipine | rel=r_associated | relid=0 | w=30
- en:bencyclane --
r_associated #0: 30 / 0.698 ->
en:mibefradil
n1=en:bencyclane | n2=en:mibefradil | rel=r_associated | relid=0 | w=30
- en:bencyclane --
r_associated #0: 29 / 0.674 ->
en:benidipine
n1=en:bencyclane | n2=en:benidipine | rel=r_associated | relid=0 | w=29
- en:bencyclane --
r_associated #0: 29 / 0.674 ->
en:cycloheptanes
n1=en:bencyclane | n2=en:cycloheptanes | rel=r_associated | relid=0 | w=29
- en:bencyclane --
r_associated #0: 29 / 0.674 ->
en:dagapamil
n1=en:bencyclane | n2=en:dagapamil | rel=r_associated | relid=0 | w=29
- en:bencyclane --
r_associated #0: 29 / 0.674 ->
en:ethaverine
n1=en:bencyclane | n2=en:ethaverine | rel=r_associated | relid=0 | w=29
- en:bencyclane --
r_associated #0: 29 / 0.674 ->
en:fludilat
n1=en:bencyclane | n2=en:fludilat | rel=r_associated | relid=0 | w=29
- en:bencyclane --
r_associated #0: 29 / 0.674 ->
en:gapona
n1=en:bencyclane | n2=en:gapona | rel=r_associated | relid=0 | w=29
- en:bencyclane --
r_associated #0: 29 / 0.674 ->
en:lercanidipine hydrochloride
n1=en:bencyclane | n2=en:lercanidipine hydrochloride | rel=r_associated | relid=0 | w=29
- en:bencyclane --
r_associated #0: 29 / 0.674 ->
en:nifedipine
n1=en:bencyclane | n2=en:nifedipine | rel=r_associated | relid=0 | w=29
- en:bencyclane --
r_associated #0: 29 / 0.674 ->
en:therapeutic use - qualifier
n1=en:bencyclane | n2=en:therapeutic use - qualifier | rel=r_associated | relid=0 | w=29
- en:bencyclane --
r_associated #0: 28 / 0.651 ->
en:agonists
n1=en:bencyclane | n2=en:agonists | rel=r_associated | relid=0 | w=28
- en:bencyclane --
r_associated #0: 28 / 0.651 ->
en:brinazarone
n1=en:bencyclane | n2=en:brinazarone | rel=r_associated | relid=0 | w=28
- en:bencyclane --
r_associated #0: 28 / 0.651 ->
en:cloxacepride
n1=en:bencyclane | n2=en:cloxacepride | rel=r_associated | relid=0 | w=28
- en:bencyclane --
r_associated #0: 28 / 0.651 ->
en:dopropidil
n1=en:bencyclane | n2=en:dopropidil | rel=r_associated | relid=0 | w=28
- en:bencyclane --
r_associated #0: 28 / 0.651 ->
en:exposure as collected domain
n1=en:bencyclane | n2=en:exposure as collected domain | rel=r_associated | relid=0 | w=28
- en:bencyclane --
r_associated #0: 28 / 0.651 ->
en:flunarizine hydrochloride
n1=en:bencyclane | n2=en:flunarizine hydrochloride | rel=r_associated | relid=0 | w=28
- en:bencyclane --
r_associated #0: 28 / 0.651 ->
en:fluxema
n1=en:bencyclane | n2=en:fluxema | rel=r_associated | relid=0 | w=28
- en:bencyclane --
r_associated #0: 28 / 0.651 ->
en:furnidipine
n1=en:bencyclane | n2=en:furnidipine | rel=r_associated | relid=0 | w=28
- en:bencyclane --
r_associated #0: 28 / 0.651 ->
en:iprotiazem
n1=en:bencyclane | n2=en:iprotiazem | rel=r_associated | relid=0 | w=28
- en:bencyclane --
r_associated #0: 28 / 0.651 ->
en:riodipine
n1=en:bencyclane | n2=en:riodipine | rel=r_associated | relid=0 | w=28
- en:bencyclane --
r_associated #0: 28 / 0.651 ->
en:tropolone
n1=en:bencyclane | n2=en:tropolone | rel=r_associated | relid=0 | w=28
- en:bencyclane --
r_associated #0: 27 / 0.628 ->
en:hydroxybencyclane
n1=en:bencyclane | n2=en:hydroxybencyclane | rel=r_associated | relid=0 | w=27
- en:bencyclane --
r_associated #0: 27 / 0.628 ->
en:nictiazem
n1=en:bencyclane | n2=en:nictiazem | rel=r_associated | relid=0 | w=27
- en:bencyclane --
r_associated #0: 27 / 0.628 ->
en:piprofurol
n1=en:bencyclane | n2=en:piprofurol | rel=r_associated | relid=0 | w=27
- en:bencyclane --
r_associated #0: 26 / 0.605 ->
en:azelnidipine
n1=en:bencyclane | n2=en:azelnidipine | rel=r_associated | relid=0 | w=26
- en:bencyclane --
r_associated #0: 26 / 0.605 ->
en:desoblit
n1=en:bencyclane | n2=en:desoblit | rel=r_associated | relid=0 | w=26
- en:bencyclane --
r_associated #0: 26 / 0.605 ->
en:diclofurime
n1=en:bencyclane | n2=en:diclofurime | rel=r_associated | relid=0 | w=26
- en:bencyclane --
r_associated #0: 26 / 0.605 ->
en:niguldipine
n1=en:bencyclane | n2=en:niguldipine | rel=r_associated | relid=0 | w=26
- en:bencyclane --
r_associated #0: 23 / 0.535 ->
en:standards characteristics
n1=en:bencyclane | n2=en:standards characteristics | rel=r_associated | relid=0 | w=23
- en:bencyclane --
r_associated #0: 22 / 0.512 ->
en:dilangio compositu
n1=en:bencyclane | n2=en:dilangio compositu | rel=r_associated | relid=0 | w=22
- en:bencyclane --
r_associated #0: 21 / 0.488 ->
en:immunology aspects
n1=en:bencyclane | n2=en:immunology aspects | rel=r_associated | relid=0 | w=21
- en:bencyclane --
r_associated #0: 21 / 0.488 ->
en:mechanism of action qualifier
n1=en:bencyclane | n2=en:mechanism of action qualifier | rel=r_associated | relid=0 | w=21
- en:bencyclane --
r_associated #0: 21 / 0.488 ->
en:pharmacokinetic aspects
n1=en:bencyclane | n2=en:pharmacokinetic aspects | rel=r_associated | relid=0 | w=21
- en:bencyclane --
r_associated #0: 20 / 0.465 ->
en:24 hr felodipine 2.5 mg extended release oral tablet
n1=en:bencyclane | n2=en:24 hr felodipine 2.5 mg extended release oral tablet | rel=r_associated | relid=0 | w=20
- en:bencyclane --
r_associated #0: 20 / 0.465 ->
en:24 hr felodipine 5 mg extended release oral tablet
n1=en:bencyclane | n2=en:24 hr felodipine 5 mg extended release oral tablet | rel=r_associated | relid=0 | w=20
- en:bencyclane --
r_associated #0: 20 / 0.465 ->
en:amlodipine maleate
n1=en:bencyclane | n2=en:amlodipine maleate | rel=r_associated | relid=0 | w=20
- en:bencyclane --
r_associated #0: 20 / 0.465 ->
en:anthrax vaccine adsorbed
n1=en:bencyclane | n2=en:anthrax vaccine adsorbed | rel=r_associated | relid=0 | w=20
- en:bencyclane --
r_associated #0: 20 / 0.465 ->
en:bluefish allergenic extract
n1=en:bencyclane | n2=en:bluefish allergenic extract | rel=r_associated | relid=0 | w=20
- en:bencyclane --
r_associated #0: 20 / 0.465 ->
en:bos taurus hip joint preparation
n1=en:bencyclane | n2=en:bos taurus hip joint preparation | rel=r_associated | relid=0 | w=20
- en:bencyclane --
r_associated #0: 20 / 0.465 ->
en:dihydropyridine calcium channel blocker [epc]
n1=en:bencyclane | n2=en:dihydropyridine calcium channel blocker [epc] | rel=r_associated | relid=0 | w=20
- en:bencyclane --
r_associated #0: 20 / 0.465 ->
en:fantofarone
n1=en:bencyclane | n2=en:fantofarone | rel=r_associated | relid=0 | w=20
- en:bencyclane --
r_associated #0: 20 / 0.465 ->
en:fda established names and unique ingredient identifier codes terminology
n1=en:bencyclane | n2=en:fda established names and unique ingredient identifier codes terminology | rel=r_associated | relid=0 | w=20
- en:bencyclane --
r_associated #0: 20 / 0.465 ->
en:oxobencyclane
n1=en:bencyclane | n2=en:oxobencyclane | rel=r_associated | relid=0 | w=20
- en:bencyclane --
r_associated #0: 20 / 0.465 ->
en:pinaverium bromide
n1=en:bencyclane | n2=en:pinaverium bromide | rel=r_associated | relid=0 | w=20
- en:bencyclane --
r_associated #0: 20 / 0.465 ->
en:sesquiterpenes, guaiane
n1=en:bencyclane | n2=en:sesquiterpenes, guaiane | rel=r_associated | relid=0 | w=20
- en:bencyclane --
r_associated #0: 20 / 0.465 ->
en:teludipine hydrochloride
n1=en:bencyclane | n2=en:teludipine hydrochloride | rel=r_associated | relid=0 | w=20
- en:bencyclane --
r_associated #0: 20 / 0.465 ->
en:tetrandrine
n1=en:bencyclane | n2=en:tetrandrine | rel=r_associated | relid=0 | w=20
- en:bencyclane --
r_associated #0: 20 / 0.465 ->
lacidipine
n1=en:bencyclane | n2=lacidipine | rel=r_associated | relid=0 | w=20
- en:bencyclane --
r_associated #0: 20 / 0.465 ->
nisoldipine
n1=en:bencyclane | n2=nisoldipine | rel=r_associated | relid=0 | w=20
- en:bencyclane --
r_associated #0: 1 / 0.023 ->
en:vasodilating agent
n1=en:bencyclane | n2=en:vasodilating agent | rel=r_associated | relid=0 | w=1
| ≈ 91 relations entrantes
- en:nisoldipine ---
r_associated #0: 56 -->
en:bencyclane
n1=en:nisoldipine | n2=en:bencyclane | rel=r_associated | relid=0 | w=56
- nisoldipine ---
r_associated #0: 55 -->
en:bencyclane
n1=nisoldipine | n2=en:bencyclane | rel=r_associated | relid=0 | w=55
- en:lacidipine ---
r_associated #0: 51 -->
en:bencyclane
n1=en:lacidipine | n2=en:bencyclane | rel=r_associated | relid=0 | w=51
- lacidipine ---
r_associated #0: 50 -->
en:bencyclane
n1=lacidipine | n2=en:bencyclane | rel=r_associated | relid=0 | w=50
- en:24 hr felodipine 5 mg extended release oral tablet ---
r_associated #0: 43 -->
en:bencyclane
n1=en:24 hr felodipine 5 mg extended release oral tablet | n2=en:bencyclane | rel=r_associated | relid=0 | w=43
- en:immunology aspects ---
r_associated #0: 36 -->
en:bencyclane
n1=en:immunology aspects | n2=en:bencyclane | rel=r_associated | relid=0 | w=36
- en:bepridil ---
r_associated #0: 35 -->
en:bencyclane
n1=en:bepridil | n2=en:bencyclane | rel=r_associated | relid=0 | w=35
- en:desoblit ---
r_associated #0: 35 -->
en:bencyclane
n1=en:desoblit | n2=en:bencyclane | rel=r_associated | relid=0 | w=35
- en:standards characteristics ---
r_associated #0: 35 -->
en:bencyclane
n1=en:standards characteristics | n2=en:bencyclane | rel=r_associated | relid=0 | w=35
- en:therapeutic use - qualifier ---
r_associated #0: 35 -->
en:bencyclane
n1=en:therapeutic use - qualifier | n2=en:bencyclane | rel=r_associated | relid=0 | w=35
- en:azulenes ---
r_associated #0: 34 -->
en:bencyclane
n1=en:azulenes | n2=en:bencyclane | rel=r_associated | relid=0 | w=34
- en:bluefish allergenic extract ---
r_associated #0: 34 -->
en:bencyclane
n1=en:bluefish allergenic extract | n2=en:bencyclane | rel=r_associated | relid=0 | w=34
- en:exposure as collected domain ---
r_associated #0: 34 -->
en:bencyclane
n1=en:exposure as collected domain | n2=en:bencyclane | rel=r_associated | relid=0 | w=34
- en:tetrandrine ---
r_associated #0: 34 -->
en:bencyclane
n1=en:tetrandrine | n2=en:bencyclane | rel=r_associated | relid=0 | w=34
- en:bencyclane fumarate ---
r_associated #0: 32 -->
en:bencyclane
n1=en:bencyclane fumarate | n2=en:bencyclane | rel=r_associated | relid=0 | w=32
- en:pharmacokinetic aspects ---
r_associated #0: 32 -->
en:bencyclane
n1=en:pharmacokinetic aspects | n2=en:bencyclane | rel=r_associated | relid=0 | w=32
- en:sesquiterpenes, guaiane ---
r_associated #0: 32 -->
en:bencyclane
n1=en:sesquiterpenes, guaiane | n2=en:bencyclane | rel=r_associated | relid=0 | w=32
- en:anthrax vaccine adsorbed ---
r_associated #0: 31 -->
en:bencyclane
n1=en:anthrax vaccine adsorbed | n2=en:bencyclane | rel=r_associated | relid=0 | w=31
- en:dihydropyridine calcium channel blocker [epc] ---
r_associated #0: 31 -->
en:bencyclane
n1=en:dihydropyridine calcium channel blocker [epc] | n2=en:bencyclane | rel=r_associated | relid=0 | w=31
- en:24 hr felodipine 2.5 mg extended release oral tablet ---
r_associated #0: 30 -->
en:bencyclane
n1=en:24 hr felodipine 2.5 mg extended release oral tablet | n2=en:bencyclane | rel=r_associated | relid=0 | w=30
- en:amlodipine besylate ---
r_associated #0: 30 -->
en:bencyclane
n1=en:amlodipine besylate | n2=en:bencyclane | rel=r_associated | relid=0 | w=30
- en:diltiazem hydrochloride ---
r_associated #0: 30 -->
en:bencyclane
n1=en:diltiazem hydrochloride | n2=en:bencyclane | rel=r_associated | relid=0 | w=30
- en:levemopamil ---
r_associated #0: 30 -->
en:bencyclane
n1=en:levemopamil | n2=en:bencyclane | rel=r_associated | relid=0 | w=30
- en:nexopamil ---
r_associated #0: 30 -->
en:bencyclane
n1=en:nexopamil | n2=en:bencyclane | rel=r_associated | relid=0 | w=30
- en:pinaverium bromide ---
r_associated #0: 30 -->
en:bencyclane
n1=en:pinaverium bromide | n2=en:bencyclane | rel=r_associated | relid=0 | w=30
- en:teludipine hydrochloride ---
r_associated #0: 30 -->
en:bencyclane
n1=en:teludipine hydrochloride | n2=en:bencyclane | rel=r_associated | relid=0 | w=30
- en:diclofurime ---
r_associated #0: 29 -->
en:bencyclane
n1=en:diclofurime | n2=en:bencyclane | rel=r_associated | relid=0 | w=29
- en:lercanidipine hydrochloride ---
r_associated #0: 29 -->
en:bencyclane
n1=en:lercanidipine hydrochloride | n2=en:bencyclane | rel=r_associated | relid=0 | w=29
- en:mechanism of action qualifier ---
r_associated #0: 29 -->
en:bencyclane
n1=en:mechanism of action qualifier | n2=en:bencyclane | rel=r_associated | relid=0 | w=29
- en:mibefradil ---
r_associated #0: 29 -->
en:bencyclane
n1=en:mibefradil | n2=en:bencyclane | rel=r_associated | relid=0 | w=29
- en:amlodipine maleate ---
r_associated #0: 28 -->
en:bencyclane
n1=en:amlodipine maleate | n2=en:bencyclane | rel=r_associated | relid=0 | w=28
- en:carboxyamidotriazole ---
r_associated #0: 28 -->
en:bencyclane
n1=en:carboxyamidotriazole | n2=en:bencyclane | rel=r_associated | relid=0 | w=28
- en:ethaverine ---
r_associated #0: 28 -->
en:bencyclane
n1=en:ethaverine | n2=en:bencyclane | rel=r_associated | relid=0 | w=28
- en:falipamil ---
r_associated #0: 28 -->
en:bencyclane
n1=en:falipamil | n2=en:bencyclane | rel=r_associated | relid=0 | w=28
- en:flunarizine hydrochloride ---
r_associated #0: 28 -->
en:bencyclane
n1=en:flunarizine hydrochloride | n2=en:bencyclane | rel=r_associated | relid=0 | w=28
- en:hydroxybencyclane ---
r_associated #0: 28 -->
en:bencyclane
n1=en:hydroxybencyclane | n2=en:bencyclane | rel=r_associated | relid=0 | w=28
- en:nictiazem ---
r_associated #0: 28 -->
en:bencyclane
n1=en:nictiazem | n2=en:bencyclane | rel=r_associated | relid=0 | w=28
- en:oxobencyclane ---
r_associated #0: 28 -->
en:bencyclane
n1=en:oxobencyclane | n2=en:bencyclane | rel=r_associated | relid=0 | w=28
- en:benidipine ---
r_associated #0: 27 -->
en:bencyclane
n1=en:benidipine | n2=en:bencyclane | rel=r_associated | relid=0 | w=27
- en:bos taurus hip joint preparation ---
r_associated #0: 27 -->
en:bencyclane
n1=en:bos taurus hip joint preparation | n2=en:bencyclane | rel=r_associated | relid=0 | w=27
- en:cycloheptanes ---
r_associated #0: 27 -->
en:bencyclane
n1=en:cycloheptanes | n2=en:bencyclane | rel=r_associated | relid=0 | w=27
- en:efonidipine ---
r_associated #0: 27 -->
en:bencyclane
n1=en:efonidipine | n2=en:bencyclane | rel=r_associated | relid=0 | w=27
- en:fluxema ---
r_associated #0: 27 -->
en:bencyclane
n1=en:fluxema | n2=en:bencyclane | rel=r_associated | relid=0 | w=27
- en:halidor ---
r_associated #0: 27 -->
en:bencyclane
n1=en:halidor | n2=en:bencyclane | rel=r_associated | relid=0 | w=27
- en:monatepil ---
r_associated #0: 27 -->
en:bencyclane
n1=en:monatepil | n2=en:bencyclane | rel=r_associated | relid=0 | w=27
- en:niguldipine ---
r_associated #0: 27 -->
en:bencyclane
n1=en:niguldipine | n2=en:bencyclane | rel=r_associated | relid=0 | w=27
- en:perhexiline maleate ---
r_associated #0: 27 -->
en:bencyclane
n1=en:perhexiline maleate | n2=en:bencyclane | rel=r_associated | relid=0 | w=27
- en:agonists ---
r_associated #0: 26 -->
en:bencyclane
n1=en:agonists | n2=en:bencyclane | rel=r_associated | relid=0 | w=26
- en:dilangio compositu ---
r_associated #0: 26 -->
en:bencyclane
n1=en:dilangio compositu | n2=en:bencyclane | rel=r_associated | relid=0 | w=26
- en:fantofarone ---
r_associated #0: 26 -->
en:bencyclane
n1=en:fantofarone | n2=en:bencyclane | rel=r_associated | relid=0 | w=26
- en:fda established names and unique ingredient identifier codes terminology ---
r_associated #0: 26 -->
en:bencyclane
n1=en:fda established names and unique ingredient identifier codes terminology | n2=en:bencyclane | rel=r_associated | relid=0 | w=26
- en:flordipine ---
r_associated #0: 26 -->
en:bencyclane
n1=en:flordipine | n2=en:bencyclane | rel=r_associated | relid=0 | w=26
- en:fludilat ---
r_associated #0: 26 -->
en:bencyclane
n1=en:fludilat | n2=en:bencyclane | rel=r_associated | relid=0 | w=26
- en:gallopamil hydrochloride ---
r_associated #0: 26 -->
en:bencyclane
n1=en:gallopamil hydrochloride | n2=en:bencyclane | rel=r_associated | relid=0 | w=26
- en:gapona ---
r_associated #0: 26 -->
en:bencyclane
n1=en:gapona | n2=en:bencyclane | rel=r_associated | relid=0 | w=26
- en:riodipine ---
r_associated #0: 26 -->
en:bencyclane
n1=en:riodipine | n2=en:bencyclane | rel=r_associated | relid=0 | w=26
- en:belfosdil ---
r_associated #0: 25 -->
en:bencyclane
n1=en:belfosdil | n2=en:bencyclane | rel=r_associated | relid=0 | w=25
- en:caroverine hydrochloride ---
r_associated #0: 25 -->
en:bencyclane
n1=en:caroverine hydrochloride | n2=en:bencyclane | rel=r_associated | relid=0 | w=25
- en:clevidipine ---
r_associated #0: 25 -->
en:bencyclane
n1=en:clevidipine | n2=en:bencyclane | rel=r_associated | relid=0 | w=25
- en:diproteverine ---
r_associated #0: 25 -->
en:bencyclane
n1=en:diproteverine | n2=en:bencyclane | rel=r_associated | relid=0 | w=25
- en:iprotiazem ---
r_associated #0: 25 -->
en:bencyclane
n1=en:iprotiazem | n2=en:bencyclane | rel=r_associated | relid=0 | w=25
- en:nitrendipine ---
r_associated #0: 25 -->
en:bencyclane
n1=en:nitrendipine | n2=en:bencyclane | rel=r_associated | relid=0 | w=25
- en:brinazarone ---
r_associated #0: 24 -->
en:bencyclane
n1=en:brinazarone | n2=en:bencyclane | rel=r_associated | relid=0 | w=24
- en:dagapamil ---
r_associated #0: 24 -->
en:bencyclane
n1=en:dagapamil | n2=en:bencyclane | rel=r_associated | relid=0 | w=24
- en:dexniguldipine ---
r_associated #0: 24 -->
en:bencyclane
n1=en:dexniguldipine | n2=en:bencyclane | rel=r_associated | relid=0 | w=24
- en:manidipine ---
r_associated #0: 24 -->
en:bencyclane
n1=en:manidipine | n2=en:bencyclane | rel=r_associated | relid=0 | w=24
- en:piprofurol ---
r_associated #0: 24 -->
en:bencyclane
n1=en:piprofurol | n2=en:bencyclane | rel=r_associated | relid=0 | w=24
- en:anipamil ---
r_associated #0: 23 -->
en:bencyclane
n1=en:anipamil | n2=en:bencyclane | rel=r_associated | relid=0 | w=23
- en:nicardipine ---
r_associated #0: 23 -->
en:bencyclane
n1=en:nicardipine | n2=en:bencyclane | rel=r_associated | relid=0 | w=23
- en:nifedipine ---
r_associated #0: 23 -->
en:bencyclane
n1=en:nifedipine | n2=en:bencyclane | rel=r_associated | relid=0 | w=23
- en:nilvadipine ---
r_associated #0: 23 -->
en:bencyclane
n1=en:nilvadipine | n2=en:bencyclane | rel=r_associated | relid=0 | w=23
- en:olradipine ---
r_associated #0: 23 -->
en:bencyclane
n1=en:olradipine | n2=en:bencyclane | rel=r_associated | relid=0 | w=23
- en:semotiadil ---
r_associated #0: 23 -->
en:bencyclane
n1=en:semotiadil | n2=en:bencyclane | rel=r_associated | relid=0 | w=23
- en:diltiazem ---
r_associated #0: 22 -->
en:bencyclane
n1=en:diltiazem | n2=en:bencyclane | rel=r_associated | relid=0 | w=22
- en:dopropidil ---
r_associated #0: 22 -->
en:bencyclane
n1=en:dopropidil | n2=en:bencyclane | rel=r_associated | relid=0 | w=22
- en:felodipine ---
r_associated #0: 22 -->
en:bencyclane
n1=en:felodipine | n2=en:bencyclane | rel=r_associated | relid=0 | w=22
- en:tropolone ---
r_associated #0: 22 -->
en:bencyclane
n1=en:tropolone | n2=en:bencyclane | rel=r_associated | relid=0 | w=22
- en:azelnidipine ---
r_associated #0: 21 -->
en:bencyclane
n1=en:azelnidipine | n2=en:bencyclane | rel=r_associated | relid=0 | w=21
- en:cloxacepride ---
r_associated #0: 21 -->
en:bencyclane
n1=en:cloxacepride | n2=en:bencyclane | rel=r_associated | relid=0 | w=21
- en:elgodipine ---
r_associated #0: 21 -->
en:bencyclane
n1=en:elgodipine | n2=en:bencyclane | rel=r_associated | relid=0 | w=21
- en:furnidipine ---
r_associated #0: 21 -->
en:bencyclane
n1=en:furnidipine | n2=en:bencyclane | rel=r_associated | relid=0 | w=21
- en:lifarizine ---
r_associated #0: 21 -->
en:bencyclane
n1=en:lifarizine | n2=en:bencyclane | rel=r_associated | relid=0 | w=21
- Lacidipine ---
r_associated #0: 10 -->
en:bencyclane
n1=Lacidipine | n2=en:bencyclane | rel=r_associated | relid=0 | w=10
- Nisoldipine ---
r_associated #0: 10 -->
en:bencyclane
n1=Nisoldipine | n2=en:bencyclane | rel=r_associated | relid=0 | w=10
- diltiazem ---
r_associated #0: 10 -->
en:bencyclane
n1=diltiazem | n2=en:bencyclane | rel=r_associated | relid=0 | w=10
- félodipine ---
r_associated #0: 10 -->
en:bencyclane
n1=félodipine | n2=en:bencyclane | rel=r_associated | relid=0 | w=10
- manidipine ---
r_associated #0: 10 -->
en:bencyclane
n1=manidipine | n2=en:bencyclane | rel=r_associated | relid=0 | w=10
- nicardipine ---
r_associated #0: 10 -->
en:bencyclane
n1=nicardipine | n2=en:bencyclane | rel=r_associated | relid=0 | w=10
- nifédipine ---
r_associated #0: 10 -->
en:bencyclane
n1=nifédipine | n2=en:bencyclane | rel=r_associated | relid=0 | w=10
- nitrendipine ---
r_associated #0: 10 -->
en:bencyclane
n1=nitrendipine | n2=en:bencyclane | rel=r_associated | relid=0 | w=10
- tropolone ---
r_associated #0: 5 -->
en:bencyclane
n1=tropolone | n2=en:bencyclane | rel=r_associated | relid=0 | w=5
|